[A measles epidemic in an adequately vaccinated middle school population]. 1994

M J van Eijndhoven, and H C Rümke, and A Bosman, and W C van Dijk, and R Hirsch, and R S van Binnendijk
Gemeenschappelijke Gezondheidsdienst Zuid-Oost Utrecht, Zeist.

OBJECTIVE To assess the extent of a measles epidemic in a secondary school. METHODS Retrospective and questionnaire investigation. METHODS Secondary school, Bilthoven. METHODS Questionnaire followed by laboratory testing for measles and other infectious diseases with exanthema. RESULTS The response rate was 99% (935/949 pupils, aged 12-21 years, vaccination rate 92%). Seventy-seven students underwent laboratory investigations. Measles virus was isolated in 2 suspected patients. Thirty-three of 37 patients with clinical or laboratory criteria of measles had been vaccinated. Complications of measles were not detected. Infection was also detected in patients with relatively few or atypical symptoms. The protective efficacy of measles vaccine could be determined because the attack rate of the school population was less than 5%. CONCLUSIONS Primary failure of the measles vaccine might be the cause of the minor epidemic but the results do not cast doubt on the efficacy of the current measles vaccination programme.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D008297 Male Males
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D008459 Measles virus The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children. Edmonston virus
D009426 Netherlands Country located in EUROPE. It is bordered by the NORTH SEA, BELGIUM, and GERMANY. Constituent areas are Aruba, Curacao, and Sint Maarten, formerly included in the NETHERLANDS ANTILLES. Holland,Kingdom of the Netherlands
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M J van Eijndhoven, and H C Rümke, and A Bosman, and W C van Dijk, and R Hirsch, and R S van Binnendijk
March 1995, Nederlands tijdschrift voor geneeskunde,
M J van Eijndhoven, and H C Rümke, and A Bosman, and W C van Dijk, and R Hirsch, and R S van Binnendijk
March 1977, The New England journal of medicine,
M J van Eijndhoven, and H C Rümke, and A Bosman, and W C van Dijk, and R Hirsch, and R S van Binnendijk
November 2005, PLoS medicine,
M J van Eijndhoven, and H C Rümke, and A Bosman, and W C van Dijk, and R Hirsch, and R S van Binnendijk
November 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
M J van Eijndhoven, and H C Rümke, and A Bosman, and W C van Dijk, and R Hirsch, and R S van Binnendijk
January 2015, Virus research,
M J van Eijndhoven, and H C Rümke, and A Bosman, and W C van Dijk, and R Hirsch, and R S van Binnendijk
July 1992, Journal of clinical microbiology,
M J van Eijndhoven, and H C Rümke, and A Bosman, and W C van Dijk, and R Hirsch, and R S van Binnendijk
December 1965, Northwest medicine,
M J van Eijndhoven, and H C Rümke, and A Bosman, and W C van Dijk, and R Hirsch, and R S van Binnendijk
December 1993, Atencion primaria,
M J van Eijndhoven, and H C Rümke, and A Bosman, and W C van Dijk, and R Hirsch, and R S van Binnendijk
January 2003, Vaccine,
M J van Eijndhoven, and H C Rümke, and A Bosman, and W C van Dijk, and R Hirsch, and R S van Binnendijk
January 1999, MMWR. Morbidity and mortality weekly report,
Copied contents to your clipboard!